diclofenac has been researched along with Nasal Polyps in 5 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Nasal Polyps: Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The degree of local eosinophilia was significantly and positively correlated with the changes in IL-5 production induced by diclofenac treatment." | 3.75 | Prostaglandin E(2) suppresses staphylococcal enterotoxin-induced eosinophilia-associated cellular responses dominantly through an E-prostanoid 2-mediated pathway in nasal polyps. ( Fujiwara, T; Haruna, T; Higaki, T; Kariya, S; Makihara, S; Nishizaki, K; Okano, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miry, T | 1 |
| van der Sar-van der Brugge, S | 1 |
| van der Rijt, AJM | 1 |
| Okano, M | 1 |
| Fujiwara, T | 1 |
| Haruna, T | 1 |
| Kariya, S | 1 |
| Makihara, S | 1 |
| Higaki, T | 1 |
| Nishizaki, K | 1 |
| Pérez-Novo, CA | 1 |
| Holtappels, G | 1 |
| Vinall, SL | 1 |
| Xue, L | 1 |
| Zhang, N | 1 |
| Bachert, C | 1 |
| Pettipher, R | 1 |
| Olze, H | 1 |
| Lau, S | 1 |
| Förster, U | 1 |
| Ostwald, J | 1 |
| Graumüller, S | 1 |
| Dommerich, S | 1 |
| Hoff, M | 1 |
5 other studies available for diclofenac and Nasal Polyps
| Article | Year |
|---|---|
[Asthma exacerbation due to preoperative NSAID use].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Asthma, Aspirin-Induced; Diclofenac; Humans; Male; Middle A | 2021 |
Prostaglandin E(2) suppresses staphylococcal enterotoxin-induced eosinophilia-associated cellular responses dominantly through an E-prostanoid 2-mediated pathway in nasal polyps.
Topics: Adult; Aged; Cells, Cultured; Cyclooxygenase Inhibitors; Cytokines; Diclofenac; Dinoprostone; Entero | 2009 |
CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anti-Idiotypic; Carbazoles; Chemotaxis, Leukocy | 2010 |
Samter's triad and eicosanoid imbalance in children with recurrent nasal polyps.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Child; Diclofenac; Drug Hypersensitivit | 2012 |
[Influence of rhinologic usual and unusual drugs on fibroblasts from nasal polyps in cell culture].
Topics: Administration, Topical; Adrenergic beta-Antagonists; Androstadienes; Anti-Inflammatory Agents; Anti | 2003 |